Margaret M. Madden
Director/Board Member chez ARRAY TECHNOLOGIES, INC.
Profil
Margaret M.
Madden is currently the Secretary, Director & Chief Governance Counsel at Array BioPharma, Inc. She is also the Director & Vice President at Anacor Pharmaceuticals LLC, the Director at Council of Institutional Investors, the Secretary, Chief Governance Counsel & Senior VP at Pfizer Inc., the Secretary & Vice President at Arena Pharmaceuticals, Inc., and the Vice President at Global Blood Therapeutics, Inc. In the past, she has worked as a Director at Medivation LLC (California) and Viatris, Inc.
Postes actifs de Margaret M. Madden
Sociétés | Poste | Début |
---|---|---|
PFIZER, INC. | General Counsel | - |
ANACOR PHARMACEUTICALS INC | Director/Board Member | 24/06/2016 |
ARRAY TECHNOLOGIES, INC. | Director/Board Member | 30/07/2019 |
ARENA PHARMACEUTICALS | Corporate Secretary | - |
GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Council of Institutional Investors
Council of Institutional Investors Miscellaneous Commercial ServicesCommercial Services Council of Institutional Investors is a non-profit association of pension funds, other employee benefit funds, endowments and foundations. The company was founded in 1985 and is headquartered in Washington DC. | Director/Board Member | 09/03/2023 |
Anciens postes connus de Margaret M. Madden
Sociétés | Poste | Fin |
---|---|---|
VIATRIS INC. | Director/Board Member | 16/11/2020 |
MEDIVATION INC | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
PFIZER, INC. | Health Technology |
VIATRIS INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Council of Institutional Investors
Council of Institutional Investors Miscellaneous Commercial ServicesCommercial Services Council of Institutional Investors is a non-profit association of pension funds, other employee benefit funds, endowments and foundations. The company was founded in 1985 and is headquartered in Washington DC. | Commercial Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |